Brief: Longeveron- Long-Term Survival Data From Elpis 1 Trial Accepted For Presentation At 2023 Scientific Sessions Of American Heart Association

Longeveron

07/09/2023 15:56

Longeveron Inc  LGVN.O :
    * LONGEVERON- LONG-TERM SURVIVAL DATA FROM ELPIS 1 TRIAL
ACCEPTED
FOR PRESENTATION AT 2023 SCIENTIFIC SESSIONS OF AMERICAN HEART
ASSOCIATION

Source text for Eikon:  ID:nGNXbJ3qB1 
Further company coverage:  LGVN.O